Evidence map›Paper›PMID 33519188›Full record

ReviewClinical ophthalmology (Auckland, N.Z.)2021

A Year of Living Dangerously: Challenges and Recommendations for Safely Performing Ophthalmic Surgery During the COVID-19 Pandemic, from Start to Finish.

Juan Pablo Salica, Constanza Potilinski, Marcia Querci, Ignacio Navarro, Juan Sebastián Rivero, Pablo Daponte, Roberto Pineda Ll, Juan E Gallo

Open access · goldAbstract readReview
In one paragraph

Review in Clinical ophthalmology (Auckland, N.Z.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Juan Pablo SalicaCommittee for Prevention of Ocular Infections, Argentinean Ophthalmology Council, Buenos Aires, Argentina.ORCID 0000-0002-8735-8667
Constanza PotilinskiNanomedicine & Vision Lab, Instituto de Investigaciones en Medicina Traslacional, Universidad Austral, CONICET, Pilar, Buenos Aires, Argentina.ORCID 0000-0003-4116-5875
Marcia QuerciDivision of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (CEMIC), Buenos Aires, Argentina.
Ignacio NavarroNanomedicine & Vision Lab, Instituto de Investigaciones en Medicina Traslacional, Universidad Austral, CONICET, Pilar, Buenos Aires, Argentina.
Juan Sebastián RiveroCommittee for Prevention of Ocular Infections, Argentinean Ophthalmology Council, Buenos Aires, Argentina.
Pablo DaponteCommittee for Prevention of Ocular Infections, Argentinean Ophthalmology Council, Buenos Aires, Argentina.
Roberto Pineda LlMassachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
Juan E GalloDepartment of Ophthalmology, Hospital Universitario Austral, Pilar, Buenos Aires, Argentina.ORCID 0000-0002-7502-6323
Consejo Nacional de Investigaciones Científicas y Técnicas · ARCentro de Educación Médica e Investigaciones Clínicas Norberto Quirno · ARMassachusetts Eye and Ear Infirmary · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has forced all nations to take an active role in infection control incorporating recommendations and measures to control viral dissemination. The epidemiological impact is very diverse and dynamic, even within the same region. Scientific knowledge regarding SARS-CoV-2 continues to improve every day with protocols needing to be updated and adjusted on a regular basis. Ophthalmology is a medical specialty identified to be at high risk for several reasons: it has very close doctor-patient contact, the virus has been detected in tears, and the ocular surface serves as a gateway to developing the infection. We have reviewed the current information on SARS-CoV-2 in the ophthalmologic field and provide up-to-date recommendations to help create protocols that can adapt to the dynamic situation of ophthalmologic institutions, patient cases, economic situations and access to diagnostic tests. This paper outlines the main recommendations regarding the initial consultation and outpatient clinics, measures to apply in the operating room (OR), and suggestions for post-surgical controls. Triage, according to the patient's conditions and eye pathology, reduction of the time the patient is at the institution, social distancing, correct use of personal protective equipment (PPE), barrier methods, hygiene, as well as other recommendations mentioned in this document, will allow physicians to take care of the visual health of the patients while reducing the impact of the COVID-19 pandemic.

Indexed as

COVID-19eyeophthalmologySARS-CoV-2surgery

Identifiers

PMID33519188
PMCPMC7837588
OpenAlexW3124558183

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.